About this trial
Several studies have evaluated the efficacy of pregabalin in reducing preoperative anxiety, with inconsistent results. Similarly, inconclusive results have been reported regarding gabapentin and its effects in reducing preoperative anxiety. A previous study reported that a single dose of gabapentin or pregabalin administered 60 minutes before surgery in adults under general anesthesia was effective in reducing acute preoperative anxiety and elevated levels of sedation before and after surgery, with pregabalin having better anxiolytic and sedative effects than gabapentin. However, no previous studies have compared the efficacy of preoperative pregabalin or gabapentin as premedication to reduce intraoperative anxiety and induce sedation in geriatric patients undergoing major surgery with regional anesthesia
Eligibility criteria
Qualifiers
geriatric patients, aged 65 years or older,
Both sex,
scheduled for elective abdominopelvic surgery with regional anesthesia
American Society of Anesthesiologists (ASA) physical status I or II.
Disqualifiers
history of allergy to gabapentin or pregabalin;
current use of gabapentin or pregabalin for other indications
history of chronic pain or chronic daily use of analgesics; a
history of epilepsy, other neurological disorders, cognitive impairment, or severe psychiatric disorders;
Trial design
Treatments tested in this trial
- One hour prior to admission to the operating room, patients will receive the study medication (as premedication) by mouth with a sip of water;
Treatment groups
Locations
1Map coordinates are unavailable for these locations. Locations are shown below instead.